These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 31092017)
1. Short term effects of intravitreal anti-vascular endothelial growth factor agents on cornea, anterior chamber, and intraocular pressure. Arslan GD; Guven D; Alkan AA; Kacar H; Demir M Cutan Ocul Toxicol; 2019 Dec; 38(4):344-348. PubMed ID: 31092017 [No Abstract] [Full Text] [Related]
2. Short-term effects of intravitreal bevacizumab on cornea and anterior chamber. Güler M; Capkın M; Simşek A; Bilak S; Bilgin B; Hakim Reyhan A; Fırat M Curr Eye Res; 2014 Oct; 39(10):989-93. PubMed ID: 24588314 [TBL] [Abstract][Full Text] [Related]
3. The early effects of intravitreal anti vascular endothelial growth factor agents on intraocular pressure and central corneal thickness. Omay E; Elgin U; Sen E; Yilmazbas P Int Ophthalmol; 2016 Oct; 36(5):665-70. PubMed ID: 26780098 [TBL] [Abstract][Full Text] [Related]
4. Long-term dynamic changes and influencing factors of corneal morphology after multiple intravitreal injections of anti-VEGF drugs. Qi Y; Li C; Ye S; Zhang Z; Li S; Zhang L Medicine (Baltimore); 2024 Apr; 103(17):e37937. PubMed ID: 38669379 [TBL] [Abstract][Full Text] [Related]
5. Intraocular pressure in patients with neovascular age-related macular degeneration switched to aflibercept injection after previous anti-vascular endothelial growth factor treatments. Rusu IM; Deobhakta A; Yoon D; Lee M; Slakter JS; Klancnik JM; Thompson D; Freund KB Retina; 2014 Nov; 34(11):2161-6. PubMed ID: 25072648 [TBL] [Abstract][Full Text] [Related]
6. The Effects of Intravitreal Ranibizumab, Aflibercept or Dexamethasone Implant Injections on Intraocular Pressure Changes. Karakurt Y; Ucak T; Taslı G; Agcayazı B; İcel E; Yılmaz H Med Sci Monit; 2018 Dec; 24():9019-9025. PubMed ID: 30542050 [TBL] [Abstract][Full Text] [Related]
7. Histological and Immunohistochemical Retinal Changes Following the Intravitreal Injection of Aflibercept, Bevacizumab and Ranibizumab in Newborn Rabbits. Cam D; Berk AT; Micili SC; Kume T; Ergur BU; Yilmaz O Curr Eye Res; 2017 Feb; 42(2):315-322. PubMed ID: 27314606 [TBL] [Abstract][Full Text] [Related]
8. The Real-World Effect of Intravitreous Anti-Vascular Endothelial Growth Factor Drugs on Intraocular Pressure: An Analysis Using the IRIS Registry. Atchison EA; Wood KM; Mattox CG; Barry CN; Lum F; MacCumber MW Ophthalmology; 2018 May; 125(5):676-682. PubMed ID: 29336897 [TBL] [Abstract][Full Text] [Related]
9. A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration. Park DH; Sun HJ; Lee SJ Int Ophthalmol; 2017 Oct; 37(5):1205-1214. PubMed ID: 27826933 [TBL] [Abstract][Full Text] [Related]
10. In vivo antivascular endothelial growth factor treatment induces corneal endothelium apoptosis in rabbits through changes in p75NTR-proNGF pathway. Gharbiya M; Bruscolini A; Sacchetti M; Rosso P; Carito V; Segatto M; Fico E; Tirassa P; Lambiase A J Cell Physiol; 2018 Nov; 233(11):8874-8883. PubMed ID: 29856479 [TBL] [Abstract][Full Text] [Related]
11. [Changes in intraocular pressure and biometric parameters of the anterior segment of the eye after intravitreal injections]. Andreeva YS; Alkharki L; Budzinskaya MV Vestn Oftalmol; 2024; 140(2. Vyp. 2):7-15. PubMed ID: 38739125 [TBL] [Abstract][Full Text] [Related]